n-acetylcysteinamide has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atlas, D; Barhum, Y; Benhar, M; Gilgun-Sherki, Y; Grinberg, L; Melamed, E; Offen, D; Reich, R | 1 |
| Atlas, D; Barhum, Y; Gilgun-Sherki, Y; Melamed, E; Offen, D | 1 |
2 other study(ies) available for n-acetylcysteinamide and Allergic Encephalomyelitis
| Article | Year |
|---|---|
A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis.
Topics: Acetylcysteine; Administration, Oral; Animals; Antimetabolites, Antineoplastic; Biological Transport; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Chelating Agents; Copper; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Erythrocytes; Female; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 9; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinases; Molecular Weight; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Sulfhydryl Compounds; Treatment Outcome | 2004 |
Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Encephalomyelitis, Autoimmune, Experimental; Gene Expression; Gene Expression Profiling; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Reactive Oxygen Species; Spinal Cord | 2005 |